Zuellig Group, one of Asia’s largest healthcare services groups, has acquired Temasek Holdings’ 20 per cent stake in drug distributor Zuellig Pharma. Temasek had reportedly sought $1 billion for its holding in the pharma company last year.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
